Delivery Order SPE2DB20D2002-SPE2DB24FL89L
Award Date
9/19/24
Potential Completion Date
9/20/24
Potential Value
$2.2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a $4,966.96 firm-fixed-price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of 4,565,734,923 units of Telmisartan 40 mg tablets. The contract is not set aside and has a completion date of September 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,324.29 firm fixed-price delivery order is for the supply of 4,566,150 units of Telmisartan 40 mg tablets. The contract has an ultimate completion date of October 21, 2024 and was awarded on October 18, 2024. This award is not associated with a set-aside program. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor. The $1,468.08 firm fixed-price delivery order is for the supply of Telmisartan 40 mg tablets. The contract has an ultimate completion date of September 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Telmisartan 40 mg tablets. The award, valued at $1,293.60, is a Firm Fixed Price delivery order contract that will run through February 4, 2025. This contract appears to be a part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,404.09 firm fixed-price delivery order is for the supply of Telmisartan 40 mg tablets, with a performance period through March 6, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,028.16 firm fixed-price delivery order is for the supply of 4,562,816,061 units of Telmisartan 40 mg tablets. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for the company to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,563,699,383 units of telmisartan 40 mg tablets. The $3,227.80 firm fixed-price delivery order contract has a completion date of February 20, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, identified as SPE2DB20D1004|SPE2DB24FF1M5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,521.84 firm-fixed-price delivery order is for 4,563,224,910 units of the drug Telmisartan 40 mg tablets. The contract has an ultimate completion date of January 4, 2024 and was awarded on January 3, 2024. This award is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, with ID SPE2DB20D2014|SPE2DB25FB74K, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,152.00 firm fixed-price delivery order is for the supply of 4,568,038,617 units of the medication Telmisartan 40 mg Tablet 30s. The contract has an ultimate completion date of April 28, 2025 and was awarded on April 25, 2025. Amerisourcebergen Drug Corp holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,441.72, is for the delivery of Telmisartan 40 mg tablets to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a total potential value of $999,999,999 and runs through November 2026. This...